2021-04-9 a57320cf7dab49a0bb726ab39d9f5d9dec10e2a5 https://www.ekathimerini.com/wp-content/uploads/2021/03/astrazeneca_reuters-2.jpg <8ab7fd8d98014c4e5e999071ed876c42396509a7>https://www.ekathimerini.com/wp-content/uploads/2021/03/astrazeneca_reuters-2.jpg 28 COVID-19 pandemic 1 /wiki/covid-19%20pandemic Greece 2 /wiki/greece Oxford–AstraZeneca 14 /wiki/oxford-astrazeneca%20covid-19%20vaccine blood clot 71 /wiki/blood%20clot vaccine 37 /wiki/covid-19%20vaccine COVID-19 pandemic Greece Oxford–AstraZeneca blood clot vaccine COVID-19 pandemic 2021-04-8 af3a052288b279ec04646375dac4c18d1b9f2265 /feed/2021/04/8/the-food-and-drug-administration-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-followi The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following reports of a possible link with cases of blood clots. 1618013256 2021-04-8 20521abbb8012423d01a1b2be356b589673b3a10 /feed/2021/04/8/the-food-and-drug-administration-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-followi The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following reports of a possible link with rare cases of blood clots. 1617987953 2021-04-8 47fd494090a7cc3781a16f72f0194b8d0f781d21 /feed/2021/04/8/the-netherlands-officially-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-due-to-concer The Netherlands officially suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old due to concerns over reports of severe blood clotting. 1617987952 2021-04-8 d68626981e8a48fd68bdc067283698e8a8567331 /feed/2021/04/8/the-food-and-drug-administration-suspends-the-use-of-the-oxford-astrazeneca-vaccine-for-those-aged-under-60-years-old-in The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old in the Philippines following reports of possible link with rare cases of blood clots. 1617927249 2021-04-8 0416dbddae6ffd2aa64d4b49065e569fbccc0996 /feed/2021/04/8/the-netherlands-officially-halts-the-use-of-the-oxford-astrazeneca-vaccine-for-those-aged-under-60-years-old-due-to-conc The Netherlands officially halts the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old due to concern over rare severe blood clotting. 1617927245 2021-04-8 23f1623a7b1f2ccd2d07193127a3bff10eac6543 /feed/2021/04/8/the-netherlands-officially-halts-the-use-of-the-vaccine-for-those-aged-under-60-years-old-due-to-concern-over-rare-sever The Netherlands officially halts the use of the vaccine for those aged under 60 years old due to concern over rare severe blood clotting. 1617915986 2021-04-8 1ef3ab42e3d937d3ec002d56d9da9c5615443e40 19 COVID-19 pandemic Oxford–AstraZeneca blood clot vaccine 4 /feed/2021/04/8/the-netherlands-officially-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-due-to-concer The Netherlands officially suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old due to concerns over reports of severe blood clotting. 2021-04-8 1ef3ab42e3d937d3ec002d56d9da9c5615443e40 /feed/2021/04/8/the-netherlands-officially-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-due-to-concer The Netherlands officially suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old due to concerns over reports of severe blood clotting. 1618013255 2021-04-8 20521abbb8012423d01a1b2be356b589673b3a10 /feed/2021/04/8/the-food-and-drug-administration-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-followi The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following reports of a possible link with rare cases of blood clots. 1617987953 2021-04-8 47fd494090a7cc3781a16f72f0194b8d0f781d21 /feed/2021/04/8/the-netherlands-officially-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-due-to-concer The Netherlands officially suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old due to concerns over reports of severe blood clotting. 1617987952 2021-04-8 d68626981e8a48fd68bdc067283698e8a8567331 /feed/2021/04/8/the-food-and-drug-administration-suspends-the-use-of-the-oxford-astrazeneca-vaccine-for-those-aged-under-60-years-old-in The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old in the Philippines following reports of possible link with rare cases of blood clots. 1617927249 2021-04-8 0416dbddae6ffd2aa64d4b49065e569fbccc0996 /feed/2021/04/8/the-netherlands-officially-halts-the-use-of-the-oxford-astrazeneca-vaccine-for-those-aged-under-60-years-old-due-to-conc The Netherlands officially halts the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old due to concern over rare severe blood clotting. 1617927245 2021-04-8 af3a052288b279ec04646375dac4c18d1b9f2265 37 COVID-19 pandemic Oxford–AstraZeneca blood clot vaccine 4 /feed/2021/04/8/the-food-and-drug-administration-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-followi The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following reports of a possible link with cases of blood clots. 2021-04-7 823afcc1d941c533623cd57d2b5417f7240dc24b /feed/2021/04/7/belgium-temporarily-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-55-years-old-following-a-report-f Belgium temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report from the European Medicines Agency that there is a "possible link" between the vaccine and very rare blood clotting cases. 1618013249 2021-04-7 45ee6be5348247cec19d4f9ff2d955ee92aa0036 /feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-following-a-report-of-a-possible Estonia suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following a report of a possible link with cases of blood clotting. 1618013249 2021-04-7 c999b79831e13c0f740e79876ddfbe0820b206b7 /feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-following-a-report-of-a-possible Estonia suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following a report of a possible link with cases of blood clotting. 1617987946 2021-04-7 68435713914e84303dcd86d56e76e393717f8d1a /feed/2021/04/7/the-ministry-of-health-temporarily-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-follo The Ministry of Health temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting. 1617858354 2021-04-7 31c5c63863486c5335de04767d7588ab718d3c0d /feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-following-report-of-possible-link Estonia suspends the use of the Oxford–AstraZeneca vaccine to people over 60 years old following report of possible link with the blood clotting cases. 1617843950 2021-04-7 dd86b27e44dedfe2ca9f290b6d349f3765408b97 33 COVID-19 pandemic Oxford–AstraZeneca blood clot vaccine 4 /feed/2021/04/7/the-ministry-of-health-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-following-a-repor The Ministry of Health restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting. 2021-04-7 45ee6be5348247cec19d4f9ff2d955ee92aa0036 /feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-following-a-report-of-a-possible Estonia suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following a report of a possible link with cases of blood clotting. 1618013249 2021-04-7 dd86b27e44dedfe2ca9f290b6d349f3765408b97 /feed/2021/04/7/the-ministry-of-health-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-following-a-repor The Ministry of Health restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting. 1618013248 2021-04-7 c999b79831e13c0f740e79876ddfbe0820b206b7 /feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-following-a-report-of-a-possible Estonia suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following a report of a possible link with cases of blood clotting. 1617987946 2021-04-7 68435713914e84303dcd86d56e76e393717f8d1a /feed/2021/04/7/the-ministry-of-health-temporarily-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-follo The Ministry of Health temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting. 1617858354 2021-04-7 31c5c63863486c5335de04767d7588ab718d3c0d /feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-following-report-of-possible-link Estonia suspends the use of the Oxford–AstraZeneca vaccine to people over 60 years old following report of possible link with the blood clotting cases. 1617843950 2021-04-7 823afcc1d941c533623cd57d2b5417f7240dc24b 26 COVID-19 pandemic Oxford–AstraZeneca blood clot vaccine 4 /feed/2021/04/7/belgium-temporarily-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-55-years-old-following-a-report-f Belgium temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report from the European Medicines Agency that there is a "possible link" between the vaccine and very rare blood clotting cases. 2021-04-4 a97069f96c779f0c070e039cdd89db64792830c4 /feed/2021/04/4/taiwan-receives-the-first-batch-consisting-199200-doses-of-the-oxford-astrazeneca-vaccine-distributed-through-the-covax Taiwan receives the first batch consisting 199,200 doses of the Oxford–AstraZeneca vaccine distributed through the COVAX initiative. 1617581342 2021-04-4 1577b797bcce1de79afde977399f29b4be961287 /feed/2021/04/4/taiwan-receives-the-first-batch-consisting-199200-doses-of-the-oxford-astrazeneca-vaccine-distributed-through-covax-ini Taiwan receives the first batch consisting 199,200 doses of the Oxford–AstraZeneca vaccine distributed through COVAX initiative. 1617555946 2021-04-4 9a3fca62ffaa3313de8fddeca259c8ed35240f1e 21 COVID-19 pandemic Oxford–AstraZeneca vaccine 3 /feed/2021/04/4/taiwan-receives-its-first-shipment-of-199200-doses-of-the-oxford-astrazeneca-vaccine-distributed-through-the-covax-init Taiwan receives its first shipment of 199,200 doses of the Oxford–AstraZeneca vaccine distributed through the COVAX initiative. 2021-03-30 4030b33e54e9fac993aacdb29f79491a5bd61895 /feed/2021/03/30/german-health-authorities-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-the-age-of-60-after-new-dat German health authorities suspends the use of the Oxford–AstraZeneca vaccine in people under the age of 60 after new data showing a rise in unusual blood clots in the head was released. 1617246348 2021-03-30 5717a991d459cacde0325955206d8d48ca701bc2 /feed/2021/03/30/germany-suspends-the-use-of-the-astrazeneca-vaccine-in-people-under-the-age-of-60-after-new-data-showing-a-rise-in-unusu Germany suspends the use of the AstraZeneca vaccine in people under the age of 60 after new data showing a rise in unusual blood clots in the head was released, of which 9 people had died. 1617138412 2021-03-30 c78f3b62e412b11096c3db6608ba7097e55897ce 16 COVID-19 pandemic Oxford–AstraZeneca blood clot vaccine 4 /feed/2021/03/30/german-health-authorities-suspend-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-the-age-of-60-after-new-data German health authorities suspend the use of the Oxford–AstraZeneca vaccine in people under the age of 60 after new data showing a rise in unusual blood clots in the head was released. 2021-03-16 8c78acc3ce800d36993bc802caa09b98c572313b /feed/2021/03/16/the-public-health-agency-of-sweden-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-pending-review-from-th The Public Health Agency of Sweden temporarily suspends the use of the Oxford-AstraZeneca vaccine pending review from the European Medicines Agency following reports on abnormal blood clotting amongst the vaccinated people. 1615950364 2021-03-16 ec926f6f72d3f349d58eb5136803a9c1461684b5 23 COVID-19 pandemic Oxford–AstraZeneca blood clot vaccine 4 /feed/2021/03/16/the-public-health-agency-of-sweden-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-pending-a-review-from The Public Health Agency of Sweden temporarily suspends the use of the Oxford-AstraZeneca vaccine pending a review from the European Medicines Agency following reports on abnormal blood clotting in vaccinated people. 2021-03-14 b0ce8bd5304031394535a28adba67d327942fa40 /feed/2021/03/14/the-netherlands-suspends-the-use-of-the-oxford-astrazeneca-vaccine-until-march-29-following-reports-of-denmark-and-norwa The Netherlands suspends the use of the Oxford–AstraZeneca vaccine until March 29 following reports of Denmark and Norway regarding possible serious side effects. 1618013032 2021-03-14 abf45e3eb0376d063099a065fd662f5aac49c177 /feed/2021/03/14/piedmont-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-after-a-teacher-in-the-town-of-biella-reportedly Piedmont temporarily suspends the use of the Oxford–AstraZeneca vaccine after a teacher in the town of Biella reportedly died after receiving the vaccine. 1618013031 2021-03-14 d6e4a20d99c066e401566a59e9120e281c8b3270 /feed/2021/03/14/piedmont-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-following-reports-about-the-death-of-a-vaccinate Piedmont temporarily suspends the use of the Oxford–AstraZeneca vaccine following reports about the death of a vaccinated teacher in the town of Biella. 1615777585 2021-03-14 274e695a48e7105b2a1b393455872a1b85a0f995 /feed/2021/03/14/italy-s-piedmont-region-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-following-reports-about-the-death Italy's Piedmont region temporarily suspends the use of the Oxford–AstraZeneca vaccine following reports about the death of a vaccinated teacher in the town of Biella. 1615767280 2021-03-14 9025978b7b1380580398b563ec69d04b13a2b28d /feed/2021/03/14/the-government-of-ireland-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-following-report-from-the-norwe The Government of Ireland temporarily suspends the use of the Oxford–AstraZeneca vaccine following report from the Norwegian Medicines Agency over serious blood clots in four people that received the vaccine, which one of them had died. 1615755995 2021-03-14 0a291c0d0d04a7ff49e4c56d33cb490c77d3edfa 8 COVID-19 pandemic Oxford–AstraZeneca blood clot vaccine 4 /feed/2021/03/14/the-government-of-ireland-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-following-reports-from-the-norw The Government of Ireland temporarily suspends the use of the Oxford–AstraZeneca vaccine following reports from the Norwegian Medicines Agency regarding serious blood clots developing in four people who received the vaccine, one of whom later died. 2021-03-11 e5b9fef891aa483f9786825dcaf0ac3357439f8c /feed/2021/03/11/danish-health-authority-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-for-two-weeks-as-a-precaution-f Danish Health Authority temporarily suspends the use of the Oxford-AstraZeneca vaccine for two weeks as a "precaution" following reports that some vaccinated people had experienced blood clots, causing one person to die after receiving the vaccine. It has not been determined whether there is a link between the vaccine and the clots. Norway and Iceland also suspended their use of the vaccine after the revelation. 1615511192 2021-03-11 d2c476d31cffd95c2ce9e16ae126e5baba9a171d /feed/2021/03/11/danish-health-authority-temporarily-suspends-the-use-of-oxford-astrazeneca-vaccine-for-two-weeks-as-precaution-followi Danish Health Authority temporarily suspends the use of Oxford-AstraZeneca vaccine for two weeks as "precaution" following reports that some vaccinated people had experienced blood clots, thus one person died after receive the vaccine. But, it cannot concludes whether there is a link between both. 1615475149 2021-03-11 2ae4392ebab24c0071277ae866af372bc5051996 21 COVID-19 pandemic Oxford–AstraZeneca blood clot vaccine 4 /feed/2021/03/11/the-danish-health-authority-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-for-two-weeks-as-a-precautio The Danish Health Authority temporarily suspends the use of the Oxford-AstraZeneca vaccine for two weeks as a "precaution" following reports that some vaccinated people had experienced blood clots, causing one person to die after receiving the vaccine. It has not been determined whether there is a link between the vaccine and the clots. Norway and Iceland have also suspended their use of the vaccine. 2021-03-5 8a1a34489ec2c7118069bcd92337f7b199269f26 /feed/2021/03/5/rwanda-begins-a-vaccination-campaign-against-covid-19-targeting-high-risk-groups-using-392000-doses-of-oxford-astrazene Rwanda begins a vaccination campaign against COVID-19 targeting high-risk groups using 392,000 doses of Oxford–AstraZeneca and Pfizer–BioNTech vaccines. 1614992722 2021-03-5 00d92e28596a5db2b817a3d3c20e4d75ebc7cf38 58 COVID-19 pandemic Oxford–AstraZeneca vaccine 3 /feed/2021/03/5/rwanda-begins-a-vaccination-campaign-against-covid-19-using-392000-doses-of-the-oxford-astrazeneca-and-pfizer-biontech Rwanda begins a vaccination campaign against COVID-19 using 392,000 doses of the Oxford–AstraZeneca and Pfizer–BioNTech vaccines. /feed/2021/04/9/greece-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-30-years-old-following-reports-of-possible-lin Ekathimerini 9 8ab7fd8d98014c4e5e999071ed876c42396509a7 4 https://www.ekathimerini.com/news/1159004/greece-restricts-use-of-astrazeneca-vaccine-to-over-30s/ 2021 Greece’s Vaccination Committee, which is responsible for designing and monitoring the push for nationwide coronavirus immunization, on Friday decided to restrict use of the AstraZeneca vaccine to people over the age of 30. Greece restricts the use of the Oxford–AstraZeneca vaccine to people over 30 years old following reports of possible link to rare blood clotting cases.